rs57081121
From SNPedia
Merged into | rs4986893 |
Orientation | plus |
Stabilized | plus |
Geno | Mag | Summary |
---|---|---|
(A;A) | homozygous CYP2C19*3 | |
(A;G) | heterozygous CYP2C19*3 | |
(G;G) | 0 | not a CYP2C19*3 carrier |
Reference | GRCh38 38.1/141 |
Chromosome | 10 |
Position | 94780653 |
Gene | CYP2C19 |
is a | snp |
is | mentioned by |
dbSNP | rs57081121 |
dbSNP (classic) | rs57081121 |
ClinGen | rs57081121 |
ebi | rs57081121 |
HLI | rs57081121 |
Exac | rs57081121 |
Gnomad | rs57081121 |
Varsome | rs57081121 |
LitVar | rs57081121 |
Map | rs57081121 |
PheGenI | rs57081121 |
Biobank | rs57081121 |
1000 genomes | rs57081121 |
hgdp | rs57081121 |
ensembl | rs57081121 |
geneview | rs57081121 |
scholar | rs57081121 |
rs57081121 | |
pharmgkb | rs57081121 |
gwascentral | rs57081121 |
openSNP | rs57081121 |
23andMe | rs57081121 |
SNPshot | rs57081121 |
SNPdbe | rs57081121 |
MSV3d | rs57081121 |
GWAS Ctlg | rs57081121 |
Status | Merged into rs4986893 |
Max Magnitude | 0 |
rs57081121(A) is an allele defining the CYP2C19*3 form of this cytochrome p450.[PMID 18521743]
As a nonfunctioning CYP2C19, this variant would be expected to be a poor metabolizer of several commonly prescribed drugs, including anti-ulcer drugs like omeprazole (trade names Losec and Prilosec), esomeprazole (trade name Nexium), and lansoprazole (Prevacid).